Pay vs Performance Disclosure
|
12 Months Ended |
Dec. 31, 2024
USD ($)
|
Dec. 31, 2023
USD ($)
|
Dec. 31, 2022
USD ($)
|
Pay vs Performance Disclosure |
|
|
|
Pay vs Performance Disclosure, Table |
Pay Versus Performance The following table provides information regarding “Compensation Actually Paid” (“CAP”) to our NEOs as determined and defined under SEC rules and does not reflect compensation actually earned, realized or received by them. The Corebridge Compensation and Management Development Committee did not consider this information in making its pay decisions for 2024. | | | | | | | | | | | | | | | | | | | | | | | | | 2024 | | | 7,810,797 | | | 12,903,410 | | | 3,274,727 | | | 4,482,113 | | | 176.40 | | | 151.20 | | | 2,203 | | | 13.2% | | | 2023 | | | 8,632,097 | | | 12,115,440 | | | 3,981,082 | | | 4,248,724 | | | 123.50 | | | 119.23 | | | 1,036 | | | 12.0% | | | 2022 | | | 8,881,597 | | | 14,151,089 | | | 4,261,914 | | | 4,107,460 | | | 99.03 | | | 109.12 | | | 8,479 | | | 11.1% | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(1)
| This table presents pay versus performance information for 2022 for Kevin Hogan (“CEO”) and Elias Habayeb, Terri Fiedler, Sabra Purtill, Todd Solash, Robert Scheinerman and Geoffrey Cornell (the “Other NEOs”), and 2023 for Kevin Hogan (“CEO”) and Elias Habayeb, Lisa Longino, Terri Fiedler, Jonathan Novak and Constance Hunter (the “Other NEOs”), and 2024 for Kevin Hogan (“CEO”) and Elias Habayeb, Lisa Longino, Terri Fiedler, and Jonathan Novak (the “Other NEOs”). CAP for 2022 was calculated based on the change in value from AIG equity pre-IPO on 12/31/2021 for Corebridge awards through 12/31/2022. AIG equity remained valued using AIG share prices on both dates. CAP for 2023 was calculated based on the change in value from AIG equity pre-IPO on 12/31/2022 for Corebridge awards through 12/31/2023. Corebridge equity awards remained valued using Corebridge prices on both dates. AIG equity awards remained valued using AIG share prices on both dates. CAP for 2024 reflects the following adjustments to the applicable amounts in the Summary Compensation Table (“SCT”): |
| | | | | | | | | | 2024 Total Reported in SCT | | | 7,810,797 | | | 3,274,727 | | | Less value of stock and option awards reported in SCT | | | (4,042,117) | | | (1,267,525) | | | Less change in Pension Value in 2024 | | | — | | | (372) | | | Plus year-end value of awards granted in 2024 that were unvested and outstanding as of 12/31/2024(a) | | | 5,233,151 | | | 1,754,368 | | | Plus change in fair value of prior year awards that were unvested and outstanding as of 12/31/2024(b) | | | 3,535,136 | | | 554,951 | | | Plus change in fair value of prior year awards that vested in 2024(c) | | | 366,443 | | | 165,964 | | | Plus value of awards granted in 2024 that vested in 2024 | | | — | | | — | | | Compensation Actually Paid for 2024 | | | 12,903,410 | | | 4,482,113 | | | | | | | | | | |
(a)
| December 31, 2024 fair value of Corebridge RSUs and Corebridge Options was calculated based on the closing Corebridge stock price on that date. |
(b)
| December 31, 2024 fair value of Corebridge RSUs and Corebridge Options was calculated based on the closing stock price on that date. December 31, 2024 fair value of AIG PSUs and AIG RSUs was calculated based on the closing AIG stock price on that date. |
(c)
| Change in fair value for awards that vested in 2024 was calculated based on the closing price on the vesting date. |
(2)
| The Peer Group TSR uses the S&P 500 Insurance Index, which we also use in the stock performance graph included in our 2024 Annual Report. The comparison assumes $100 was invested for the period starting September 15, 2022, the IPO date, through the end of the listed year for purposes of calculating the cumulative TSR of the Company and the S&P 500 Insurance Index over the measurement period. Historical stock performance is not necessarily indicative of future stock performance. |
(3)
| Net Income is derived from our Audited Consolidated Financial Statements. |
(4)
| We determined Normalized ROAE to be the most important financial performance measure used to link Company performance to CAP in 2024. Normalized ROAE is a non-GAAP financial measure. For more information on this measure, see Appendix A. |
|
|
|
Company Selected Measure Name |
Normalized ROAE
|
|
|
Named Executive Officers, Footnote |
(1)
| This table presents pay versus performance information for 2022 for Kevin Hogan (“CEO”) and Elias Habayeb, Terri Fiedler, Sabra Purtill, Todd Solash, Robert Scheinerman and Geoffrey Cornell (the “Other NEOs”), and 2023 for Kevin Hogan (“CEO”) and Elias Habayeb, Lisa Longino, Terri Fiedler, Jonathan Novak and Constance Hunter (the “Other NEOs”), and 2024 for Kevin Hogan (“CEO”) and Elias Habayeb, Lisa Longino, Terri Fiedler, and Jonathan Novak (the “Other NEOs”). CAP for 2022 was calculated based on the change in value from AIG equity pre-IPO on 12/31/2021 for Corebridge awards through 12/31/2022. AIG equity remained valued using AIG share prices on both dates. CAP for 2023 was calculated based on the change in value from AIG equity pre-IPO on 12/31/2022 for Corebridge awards through 12/31/2023. Corebridge equity awards remained valued using Corebridge prices on both dates. AIG equity awards remained valued using AIG share prices on both dates. CAP for 2024 reflects the following adjustments to the applicable amounts in the Summary Compensation Table (“SCT”): |
|
|
|
Peer Group Issuers, Footnote |
(2)
| The Peer Group TSR uses the S&P 500 Insurance Index, which we also use in the stock performance graph included in our 2024 Annual Report. The comparison assumes $100 was invested for the period starting September 15, 2022, the IPO date, through the end of the listed year for purposes of calculating the cumulative TSR of the Company and the S&P 500 Insurance Index over the measurement period. Historical stock performance is not necessarily indicative of future stock performance. |
|
|
|
PEO Total Compensation Amount |
$ 7,810,797
|
$ 8,632,097
|
$ 8,881,597
|
PEO Actually Paid Compensation Amount |
$ 12,903,410
|
12,115,440
|
14,151,089
|
Adjustment To PEO Compensation, Footnote |
(1)
| This table presents pay versus performance information for 2022 for Kevin Hogan (“CEO”) and Elias Habayeb, Terri Fiedler, Sabra Purtill, Todd Solash, Robert Scheinerman and Geoffrey Cornell (the “Other NEOs”), and 2023 for Kevin Hogan (“CEO”) and Elias Habayeb, Lisa Longino, Terri Fiedler, Jonathan Novak and Constance Hunter (the “Other NEOs”), and 2024 for Kevin Hogan (“CEO”) and Elias Habayeb, Lisa Longino, Terri Fiedler, and Jonathan Novak (the “Other NEOs”). CAP for 2022 was calculated based on the change in value from AIG equity pre-IPO on 12/31/2021 for Corebridge awards through 12/31/2022. AIG equity remained valued using AIG share prices on both dates. CAP for 2023 was calculated based on the change in value from AIG equity pre-IPO on 12/31/2022 for Corebridge awards through 12/31/2023. Corebridge equity awards remained valued using Corebridge prices on both dates. AIG equity awards remained valued using AIG share prices on both dates. CAP for 2024 reflects the following adjustments to the applicable amounts in the Summary Compensation Table (“SCT”): |
| | | | | | | | | | 2024 Total Reported in SCT | | | 7,810,797 | | | 3,274,727 | | | Less value of stock and option awards reported in SCT | | | (4,042,117) | | | (1,267,525) | | | Less change in Pension Value in 2024 | | | — | | | (372) | | | Plus year-end value of awards granted in 2024 that were unvested and outstanding as of 12/31/2024(a) | | | 5,233,151 | | | 1,754,368 | | | Plus change in fair value of prior year awards that were unvested and outstanding as of 12/31/2024(b) | | | 3,535,136 | | | 554,951 | | | Plus change in fair value of prior year awards that vested in 2024(c) | | | 366,443 | | | 165,964 | | | Plus value of awards granted in 2024 that vested in 2024 | | | — | | | — | | | Compensation Actually Paid for 2024 | | | 12,903,410 | | | 4,482,113 | | | | | | | | | | |
(a)
| December 31, 2024 fair value of Corebridge RSUs and Corebridge Options was calculated based on the closing Corebridge stock price on that date. |
(b)
| December 31, 2024 fair value of Corebridge RSUs and Corebridge Options was calculated based on the closing stock price on that date. December 31, 2024 fair value of AIG PSUs and AIG RSUs was calculated based on the closing AIG stock price on that date. |
(c)
| Change in fair value for awards that vested in 2024 was calculated based on the closing price on the vesting date. |
|
|
|
Non-PEO NEO Average Total Compensation Amount |
$ 3,274,727
|
3,981,082
|
4,261,914
|
Non-PEO NEO Average Compensation Actually Paid Amount |
$ 4,482,113
|
4,248,724
|
4,107,460
|
Adjustment to Non-PEO NEO Compensation Footnote |
(1)
| This table presents pay versus performance information for 2022 for Kevin Hogan (“CEO”) and Elias Habayeb, Terri Fiedler, Sabra Purtill, Todd Solash, Robert Scheinerman and Geoffrey Cornell (the “Other NEOs”), and 2023 for Kevin Hogan (“CEO”) and Elias Habayeb, Lisa Longino, Terri Fiedler, Jonathan Novak and Constance Hunter (the “Other NEOs”), and 2024 for Kevin Hogan (“CEO”) and Elias Habayeb, Lisa Longino, Terri Fiedler, and Jonathan Novak (the “Other NEOs”). CAP for 2022 was calculated based on the change in value from AIG equity pre-IPO on 12/31/2021 for Corebridge awards through 12/31/2022. AIG equity remained valued using AIG share prices on both dates. CAP for 2023 was calculated based on the change in value from AIG equity pre-IPO on 12/31/2022 for Corebridge awards through 12/31/2023. Corebridge equity awards remained valued using Corebridge prices on both dates. AIG equity awards remained valued using AIG share prices on both dates. CAP for 2024 reflects the following adjustments to the applicable amounts in the Summary Compensation Table (“SCT”): |
| | | | | | | | | | 2024 Total Reported in SCT | | | 7,810,797 | | | 3,274,727 | | | Less value of stock and option awards reported in SCT | | | (4,042,117) | | | (1,267,525) | | | Less change in Pension Value in 2024 | | | — | | | (372) | | | Plus year-end value of awards granted in 2024 that were unvested and outstanding as of 12/31/2024(a) | | | 5,233,151 | | | 1,754,368 | | | Plus change in fair value of prior year awards that were unvested and outstanding as of 12/31/2024(b) | | | 3,535,136 | | | 554,951 | | | Plus change in fair value of prior year awards that vested in 2024(c) | | | 366,443 | | | 165,964 | | | Plus value of awards granted in 2024 that vested in 2024 | | | — | | | — | | | Compensation Actually Paid for 2024 | | | 12,903,410 | | | 4,482,113 | | | | | | | | | | |
(a)
| December 31, 2024 fair value of Corebridge RSUs and Corebridge Options was calculated based on the closing Corebridge stock price on that date. |
(b)
| December 31, 2024 fair value of Corebridge RSUs and Corebridge Options was calculated based on the closing stock price on that date. December 31, 2024 fair value of AIG PSUs and AIG RSUs was calculated based on the closing AIG stock price on that date. |
(c)
| Change in fair value for awards that vested in 2024 was calculated based on the closing price on the vesting date. |
|
|
|
Compensation Actually Paid vs. Total Shareholder Return |
Relationship Between Compensation Actually Paid and TSR(1)  (1)
| TSR on the graph begins on Corebridge’s IPO date whereas CAP begins as of the prior fiscal year end. |
|
|
|
Compensation Actually Paid vs. Net Income |
Relationship Between Compensation Actually Paid and Net Income
|
|
|
Compensation Actually Paid vs. Company Selected Measure |
Relationship Between Compensation Actually Paid and Normalized ROAE
|
|
|
Total Shareholder Return Vs Peer Group |
Relationship Between Compensation Actually Paid and TSR(1)  (1)
| TSR on the graph begins on Corebridge’s IPO date whereas CAP begins as of the prior fiscal year end. |
|
|
|
Tabular List, Table |
Most Important Financial Performance Measures The following table presents the financial performance measures that the Company considers to be the most important in linking CAP to our NEOs for 2024 to Company performance. The measures in these tables are not ranked. Certain of these measures are non-GAAP financial measures. For more information on non-GAAP measures, see Appendix A. | | | | • | Normalized ROAE | | | • | Normalized ROAE | • | Normalized GOE | | | • | Normalized GOE | • | Normalized Operating EPS | | | • | Normalized Operating EPS | • | Adjusted AYCR excl. CATs | | | | | • | Cumulative AIG Diluted Operating EPS (AATI) Growth | | | | | • | TSR | | | | | | | | | | |
|
|
|
Total Shareholder Return Amount |
$ 176.4
|
123.5
|
99.03
|
Peer Group Total Shareholder Return Amount |
$ 151.2
|
$ 119.23
|
$ 109.12
|
Company Selected Measure Amount |
0.132
|
0.12
|
0.111
|
PEO Name |
Kevin Hogan
|
Kevin Hogan
|
Kevin Hogan
|
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest |
$ 2,203,000,000
|
$ 1,036,000,000
|
$ 8,479,000,000
|
Measure:: 1 |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Non-GAAP Measure Description |
(4)
| We determined Normalized ROAE to be the most important financial performance measure used to link Company performance to CAP in 2024. Normalized ROAE is a non-GAAP financial measure. For more information on this measure, see Appendix A. |
|
|
|
PEO | Measure:: 1 |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Name |
Normalized ROAE
|
|
|
PEO | Measure:: 2 |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Name |
Normalized GOE
|
|
|
PEO | Measure:: 3 |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Name |
Normalized Operating EPS
|
|
|
PEO | Measure:: 4 |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Name |
Adjusted AYCR excl. CATs
|
|
|
PEO | Measure:: 5 |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Name |
Cumulative AIG Diluted Operating EPS (AATI) Growth
|
|
|
PEO | Measure:: 6 |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Name |
TSR
|
|
|
PEO | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Adjustment to Compensation, Amount |
$ 0
|
|
|
PEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Adjustment to Compensation, Amount |
(4,042,117)
|
|
|
PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Adjustment to Compensation, Amount |
5,233,151
|
|
|
PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Adjustment to Compensation, Amount |
3,535,136
|
|
|
PEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Adjustment to Compensation, Amount |
0
|
|
|
PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Adjustment to Compensation, Amount |
$ 366,443
|
|
|
Non-PEO NEO | Measure:: 1 |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Name |
Normalized ROAE
|
|
|
Non-PEO NEO | Measure:: 2 |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Name |
Normalized GOE
|
|
|
Non-PEO NEO | Measure:: 3 |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Name |
Normalized Operating EPS
|
|
|
Non-PEO NEO | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Adjustment to Compensation, Amount |
$ (372)
|
|
|
Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Adjustment to Compensation, Amount |
(1,267,525)
|
|
|
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Adjustment to Compensation, Amount |
1,754,368
|
|
|
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Adjustment to Compensation, Amount |
554,951
|
|
|
Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Adjustment to Compensation, Amount |
0
|
|
|
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |
|
|
|
Pay vs Performance Disclosure |
|
|
|
Adjustment to Compensation, Amount |
$ 165,964
|
|
|
Award Timing Disclosure
|
12 Months Ended |
|
Dec. 31, 2024 |
Apr. 05, 2024
USD ($)
shares
$ / shares
|
Award Timing Disclosures [Line Items] |
|
|
Award Timing MNPI Disclosure |
Company Policies and Practices Related to the Grant of Certain Equity Awards Close in Time to the Release of Material Nonpublic Information In November 2024, the Compensation and Management Development Committee adopted an Equity Grant Policy specifying, among other things, the timing of equity grants to Section 16 Officers, including option grants, made by the Compensation and Management Development Committee. Pursuant to the policy, annual grants of equity awards to Section 16 Officers are approved by the Compensation and Management Development Committee at a pre-scheduled meeting in the first quarter of the fiscal year, and the effective grant date of such awards will be the meeting date unless the meeting date falls within a blackout period as described in our Insider Trading Policy, in which case the Compensation and Management Development Committee may approve, at its discretion, an effective grant date outside of the blackout period. The effective grant date of all other equity awards granted to Section 16 Officers, including new-hire, promotional, make whole, or special recognition equity grants will be the approval date unless the approval date falls within a blackout period, in which case the Compensation and Management Development Committee may approve, at its discretion, an effective grant date outside of the blackout period. Further, pursuant to the policy, grants of option-like awards (i.e., stock options, stock appreciation rights, and other option-like instruments) to Section 16 Officers will not occur in the period starting four business days before or ending one business day after the filing of a Form 10-K/10-Q or the filing or furnishing of a Form 8-K containing material nonpublic information, including earnings information, but excluding a Form 8-K that discloses only the grant of a material new option-like award. In compliance with Item 402(x) of Regulation S-K, the table below sets forth certain information regarding a grant of stock options to one NEO during the period beginning four business days before, and ending one business day after the filing of a periodic report on Form 10-Q or Form 10-K, or the filing or furnishing of a current report on Form 8-K. | | | | | | | | | | | | | | | | | | | Kevin Hogan(1) | | | 4/5/2024 | | | 129,701 | | | $28.68 | | | $999,995 | | | +2.1% | | | | | | | | | | | | | | | | | | | |
(1)
| The Section 16 Sub-Committee granted additional stock options to Kevin Hogan, which were made on the same day that we filed a current report on Form 8-K disclosing a director resignation. |
|
|
Award Timing Method |
Pursuant to the policy, annual grants of equity awards to Section 16 Officers are approved by the Compensation and Management Development Committee at a pre-scheduled meeting in the first quarter of the fiscal year, and the effective grant date of such awards will be the meeting date unless the meeting date falls within a blackout period as described in our Insider Trading Policy, in which case the Compensation and Management Development Committee may approve, at its discretion, an effective grant date outside of the blackout period. The effective grant date of all other equity awards granted to Section 16 Officers, including new-hire, promotional, make whole, or special recognition equity grants will be the approval date unless the approval date falls within a blackout period, in which case the Compensation and Management Development Committee may approve, at its discretion, an effective grant date outside of the blackout period.
|
|
Award Timing Predetermined |
true
|
|
Award Timing MNPI Considered |
true
|
|
Award Timing, How MNPI Considered |
Further, pursuant to the policy, grants of option-like awards (i.e., stock options, stock appreciation rights, and other option-like instruments) to Section 16 Officers will not occur in the period starting four business days before or ending one business day after the filing of a Form 10-K/10-Q or the filing or furnishing of a Form 8-K containing material nonpublic information, including earnings information, but excluding a Form 8-K that discloses only the grant of a material new option-like award.
|
|
Awards Close in Time to MNPI Disclosures, Table |
In compliance with Item 402(x) of Regulation S-K, the table below sets forth certain information regarding a grant of stock options to one NEO during the period beginning four business days before, and ending one business day after the filing of a periodic report on Form 10-Q or Form 10-K, or the filing or furnishing of a current report on Form 8-K. | | | | | | | | | | | | | | | | | | | Kevin Hogan(1) | | | 4/5/2024 | | | 129,701 | | | $28.68 | | | $999,995 | | | +2.1% | | | | | | | | | | | | | | | | | | | |
(1)
| The Section 16 Sub-Committee granted additional stock options to Kevin Hogan, which were made on the same day that we filed a current report on Form 8-K disclosing a director resignation. |
|
|
Kevin Hogan [Member] |
|
|
Awards Close in Time to MNPI Disclosures |
|
|
Name |
|
Kevin Hogan
|
Underlying Securities | shares |
|
129,701
|
Exercise Price | $ / shares |
|
$ 28.68
|
Fair Value as of Grant Date | $ |
|
$ 999,995
|
Underlying Security Market Price Change |
|
0.021
|